Syquant Capital SAS
- SEC CIK
- 0001766392
- Latest filing
- Jul 9, 2026
MRTX holding history
Mirati Therapeutics, Inc. in every 13F filed by Syquant Capital SAS, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
MRTX overviewAll 13F holders of MRTXFull Q2 2026 holdings
- Shares (Q1 2024)
- 0
- Sold out in Q1 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 1
- Since Q4 2023